Dougherty & Co Upgrades Hologic (HOLX) to Buy; Pending GPRO Acquisition

Article Stock Quotes (1) Comments (0)

Dougherty & Co upgraded Hologic (NASDAQ: HOLX) from Neutral to Buy with a price target of $21.00 (from $20.00).

Analyst, Junaid Husain, said, "Following last night's Q3 results, we're upgrading HOLX to Buy ahead of the pending Aug 1st close of the Gen-Probe (Nasdaq: GRPO) acquisition...Ultimately, our Buy rating is predicated on solid execution of the Gen-Probe transaction."

For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.

Shares of Hologic closed at $18.26 yesterday, with a 52 week range of $13.90-$22.16.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
• UPDATE: Howard Weil Upgrades LINN Energy (LINE) to Outperform
• B. Riley Upgrades Motorcar Parts of Americabb (MPAA) to Buy

Create E-mail Alert Related Categories

Analyst PT Change, Mergers and Acquisitions, Upgrades

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?